NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 01:30PM ET
2.09
Dollar change
-0.07
Percentage change
-3.24
%
Index- P/E- EPS (ttm)-1.94 Insider Own39.03% Shs Outstand36.55M Perf Week12.97%
Market Cap85.93M Forward P/E- EPS next Y-0.43 Insider Trans5.52% Shs Float25.07M Perf Month7.73%
Enterprise Value103.82M PEG- EPS next Q-0.17 Inst Own39.35% Short Float0.14% Perf Quarter-24.55%
Income-40.11M P/S3.62 EPS this Y65.59% Inst Trans281.50% Short Ratio1.00 Perf Half Y-46.27%
Sales23.71M P/B- EPS next Y32.81% ROA-107.92% Short Interest0.03M Perf YTD-44.12%
Book/sh-0.89 P/C4.95 EPS next 5Y- ROE- 52W High5.12 -59.18% Perf Year-55.34%
Cash/sh0.42 P/FCF- EPS past 3/5Y7.82% -10.72% ROIC- 52W Low1.61 29.81% Perf 3Y-67.09%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-19.88% -10.69% Gross Margin43.53% Volatility11.34% 8.81% Perf 5Y-
Dividend TTM- EV/Sales4.38 EPS Y/Y TTM44.67% Oper. Margin-96.74% ATR (14)0.17 Perf 10Y-
Dividend Ex-Date- Quick Ratio0.70 Sales Y/Y TTM-18.22% Profit Margin-169.15% RSI (14)58.03 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio0.81 EPS Q/Q71.72% SMA2010.00% Beta0.88 Target Price7.50
Payout- Debt/Eq- Sales Q/Q-9.92% SMA509.15% Rel Volume0.14 Prev Close2.16
Employees51 LT Debt/Eq- EarningsMay 08 AMC SMA200-30.78% Avg Volume34.53K Price2.09
IPOOct 08, 2020 Option/ShortNo / Yes EPS/Sales Surpr.-2.44% -9.32% Trades Volume4,737 Change-3.24%
Date Action Analyst Rating Change Price Target Change
Nov-02-20Initiated Truist Buy $20
Nov-02-20Initiated Piper Sandler Overweight $20
Nov-02-20Initiated Cowen Outperform $20
Nov-02-20Initiated Cantor Fitzgerald Overweight $20
Jul-01-25 08:00AM
Jun-26-25 08:00AM
May-28-25 08:00AM
May-08-25 04:05PM
May-07-25 11:38AM
04:05PM Loading…
May-01-25 04:05PM
08:00AM
Apr-22-25 04:05PM
Apr-21-25 08:00AM
Apr-14-25 08:00AM
Apr-04-25 08:00AM
Apr-03-25 08:00AM
Apr-02-25 04:05PM
Mar-27-25 04:05PM
Mar-25-25 04:05PM
04:05PM Loading…
Mar-06-25 04:05PM
Mar-05-25 07:30AM
Feb-20-25 04:05PM
Feb-03-25 06:30AM
Jan-15-25 08:15AM
Jan-14-25 08:00AM
Jan-06-25 08:00AM
Dec-02-24 08:00AM
Nov-14-24 04:05PM
Nov-13-24 04:05PM
07:27AM
Oct-29-24 04:05PM
Oct-23-24 04:05PM
Oct-17-24 04:15PM
Oct-15-24 11:01AM
08:00AM Loading…
Sep-18-24 08:00AM
Sep-06-24 04:23PM
Sep-05-24 04:05PM
Sep-03-24 04:05PM
Aug-21-24 07:00AM
Aug-20-24 07:00AM
Aug-07-24 04:05PM
Aug-01-24 04:05PM
Jul-31-24 04:05PM
Jul-30-24 04:05PM
Jul-17-24 04:15PM
07:00AM
Jul-16-24 07:00AM
Jul-11-24 04:05PM
03:24PM
Jun-17-24 08:01AM
08:00AM
May-13-24 08:00AM
May-09-24 10:55PM
04:05PM
May-02-24 04:05PM
Apr-29-24 09:00AM
Apr-24-24 04:05PM
Mar-07-24 09:53PM
04:05PM
Feb-22-24 04:05PM
Feb-20-24 10:37AM
Jan-10-24 04:05PM
Dec-18-23 08:00AM
Nov-13-23 04:05PM
Nov-09-23 08:30AM
Nov-06-23 04:05PM
Oct-18-23 08:00AM
Sep-20-23 08:30AM
Sep-19-23 08:36AM
Sep-18-23 04:08PM
Sep-08-23 08:30AM
Sep-06-23 04:05PM
Aug-30-23 08:30AM
Aug-21-23 09:42AM
Aug-15-23 05:21AM
Aug-14-23 04:05PM
Jul-31-23 04:05PM
Jul-26-23 03:29PM
Jul-17-23 04:05PM
Jul-13-23 04:30PM
May-19-23 01:45PM
08:15AM
May-13-23 08:17AM
May-11-23 09:58AM
05:51AM
May-10-23 04:05PM
May-03-23 04:05PM
10:42AM
Apr-20-23 04:30PM
Apr-17-23 06:11AM
Apr-05-23 09:55AM
Mar-27-23 06:26AM
Mar-23-23 06:08AM
Mar-22-23 04:01PM
08:30AM
Mar-20-23 12:01PM
08:00AM
Mar-15-23 04:05PM
Feb-27-23 08:15AM
Jan-31-23 08:00AM
Jan-26-23 12:00PM
09:40AM
Jan-21-23 09:58AM
Jan-09-23 08:15AM
Elutia, Inc. is a biotechnology company, which engages in the provision of biologic products to improve compatibility between medical devices and the patients who need them. It operates through the following segments: Device Protection, Women's Health, and Cardiovascular. The Device Protection segment includes biological envelope that remodels into systematically connected, vascularized tissue for the long-term pocket protection of certain cardiac and neurostimulator implantable electronic vehicles. The Women's Health segment includes pre-hydrated, human acellular dermal matrix, or HADM, that is designed to enable rapid integration, cellular repopulation and rapid revascularization at the surgical site. The Cardiovascular segment includes a variety of viable matrices, produced with a proprietary process that is designed to protect and preserve native bone cells and reduce programmable cell death, for use in bone repair and fusion procedures. The Cardiovascular segment includes a portfolio of extracellular matrices that retain the natural composition of collagen, growth factors and proteins for use in vascular and cardiac repair and pericardial closure. The company was founded by Kevin L. Rakin and Charles Randal Mills on August 6, 2015 and is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HighCape Capital, L.P.DirectorFeb 03 '25Buy2.50420,0001,050,0009,520,232Mar 13 04:30 PM
HighCape Capital, L.P.DirectorFeb 03 '25Buy2.50420,0001,050,0009,520,232Mar 13 04:28 PM
Ferguson MatthewCHIEF FINANCIAL OFFICERJul 31 '24Option Exercise1.43105,080150,002257,823Jul 31 05:00 PM